Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolic Tumor Volume on 18-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Marker of Survival in Patients With Locally Advanced or Metastatic Neuroendocrine Neoplasms Treated With 177Lutetium-DOTA-Octreotate Peptide Receptor Radionuclide Therapy.
De Silva MK, Chan DLH, Bernard EJ, Conner AJ, Mascall SL, Bailey DL, Roach PJ, Clarke SJ, Diakos CI, Pavlakis N, Schembri G. De Silva MK, et al. Among authors: diakos ci. Pancreas. 2024 Aug 1;53(7):e560-e565. doi: 10.1097/MPA.0000000000002336. Pancreas. 2024. PMID: 38986077
Prognostic and predictive biomarkers in neuroendocrine tumours.
Chan DL, Clarke SJ, Diakos CI, Roach PJ, Bailey DL, Singh S, Pavlakis N. Chan DL, et al. Among authors: diakos ci. Crit Rev Oncol Hematol. 2017 May;113:268-282. doi: 10.1016/j.critrevonc.2017.03.017. Epub 2017 Mar 18. Crit Rev Oncol Hematol. 2017. PMID: 28427516 Review.
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.
Chan DL, Pavlakis N, Schembri GP, Bernard EJ, Hsiao E, Hayes A, Barnes T, Diakos C, Khasraw M, Samra J, Eslick E, Roach PJ, Engel A, Clarke SJ, Bailey DL. Chan DL, et al. Theranostics. 2017 Mar 1;7(5):1149-1158. doi: 10.7150/thno.18068. eCollection 2017. Theranostics. 2017. PMID: 28435454 Free PMC article.
50 results